Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/7175
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHan, P.-
dc.contributor.authorStory, C.-
dc.contributor.authorMcDonald, T.-
dc.contributor.authorMrozik, K.-
dc.contributor.authorSnell, L.-
dc.date.issued2002-
dc.identifier.citationCytotherapy, 2002; 4(2):165-175-
dc.identifier.issn1465-3249-
dc.identifier.issn1477-2566-
dc.identifier.urihttp://hdl.handle.net/2440/7175-
dc.description.abstract<h4>Background</h4>Pre-B ALL cells generally elicit a weak immune host response, due to poor expression of co-stimulatory molecules and/or suppression of immune function. A possible way to enhance immunogenicity of pre-B ALL cells is to convert them to DC-like cells.<h4>Methods</h4>To study the effect of ALL cells on T-cell function, ALL cells were incubated with T adult cells activated by OKT3 MAb. Liquid culture of de novo pre-B ALL cells for 7 days, in a medium containing IL-1alpha, IL-3, IL-7, Flt 3 ligand (L) and tumor-necrosis factor alpha (TNF-alpha) produced DC-like cells. These were evaluated for morphology, viability, phenotype, as measured by flow cytometry, and function, including MLR.<h4>Results</h4>Pre-B ALL cell-lines NALM-6, BALM and de novo pre-B ALL cells failed to stimulate T cells, but suppressed stimulated T cells. The DC-like cells displayed characteristic features of DCs: filiform cytoplasmic projections, and phenotypic expression of co-stimulatory molecules CD80/86, MHC Class I and II molecules, CD83 and CD1a. Genetic monoclonality study confirmed their leukemic origin. In a 5-day MLR culture, the DC-like cells potently activated allogeneic adult and cord CD4+ and CD8+ T cells. Furthermore, both CD4+ and CD8+ T cells were primed towards a Type I. No such effect was seen with unmanipulated de novo pre-B ALL cells.<h4>Discussion</h4>DC-like cells can be generated from childhood pre-B ALL cells and are potent stimulators of adult and naïve cord CD8+ T cells via CD4+ cells. These cells may form part of an immunotherapy strategy to overcome tolerance to ALL cells.-
dc.description.statementofresponsibilityHan, P ; Story, C ; McDonald, T ; Mrozik, K ; Snell, L-
dc.language.isoen-
dc.publisherTaylor & Francis Ltd-
dc.source.urihttp://dx.doi.org/10.1080/146532402317381875-
dc.subjectB-Lymphocytes-
dc.subjectDendritic Cells-
dc.subjectT-Lymphocytes-
dc.subjectHematopoietic Stem Cells-
dc.subjectCell Line-
dc.subjectHumans-
dc.subjectImmunotherapy-
dc.subjectFlow Cytometry-
dc.subjectCell Cycle-
dc.subjectCell Differentiation-
dc.subjectPrecursor Cell Lymphoblastic Leukemia-Lymphoma-
dc.titleImmune escape mechanisms of childhood ALL and a potential countering role for DC-like leukemia cells-
dc.typeJournal article-
dc.identifier.doi10.1080/146532402317381875-
pubs.publication-statusPublished-
dc.identifier.orcidMrozik, K. [0000-0002-4890-8208]-
Appears in Collections:Aurora harvest
Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.